A bariatric surgeon says Ozempic damages the one nerve that controls weight

Dr. David Brown says the people who lose the most weight on GLP-1s are the ones who will suffer the worst side effects long term, and the reason is a nerve most doctors never mention.

Ozempic and Mounjaro Warning!  What Nobody Is Telling You!

The people who lose the most weight on Ozempic, Wegovy and Mounjaro are the people who don't need to lose as much in the first place. The people who are severely obese, the ones who need these drugs most, don't usually respond as well.

That paradox has been sitting in plain sight since the early trials, and Dr. David Brown, a bariatric surgeon who spends most of his practice on weight loss and metabolism, says it's a clue to something most doctors prescribing GLP-1s don't understand. The people who respond best are also the ones who are going to suffer the worst side effects long term.

The reason, he says, is a nerve that runs from the brain to the gut. It's called the vagus nerve. These injections bypass it entirely, and in doing so, they make it weaker. The healthier you are when you start, the more damage the drug will do.

The side effects showing up now are the first signs

In Brown's clinic, about 40 to 50 percent of the weight people lose on GLP-1s is muscle. Other clinics report the same. The published studies in JAMA show muscle loss at 38 to 40 percent of total weight loss.

The other side effect climbing fast is gastroparesis, a form of stomach paralysis. People stop the injection and can't eat. They're nauseous, vomiting, and when doctors look, the stomach isn't moving. The motor nerves and muscles that let the stomach contract and empty are paralyzed.

Brown says both of those, the muscle loss and the paralysis, are clues to what these drugs are actually doing to the nervous system.

The people who respond most impressively in weight loss to these medications are going to suffer the more severe side effects long term.Idaho Bariatric & Metabolic Institute

GLP-1 is a neurotransmitter, not a hormone

GLP-1 is a naturally occurring peptide in the human body. It's made of amino acids. The FDA calls it a hormone, but Brown says that's not quite right. In a healthy person, it's a neurotransmitter.

Here's how it's supposed to work. The gastrointestinal tract, mouth to anus, is about 30 feet long with over 400 square feet of surface area. That surface is packed with specialized sensor cells called enteroendocrine cells, or neuropod cells. They detect what's inside the intestines: sugar, fat, protein.

On the other side of those cells, a very small distance away, are nerve endings. The enteroendocrine cells release over 20 different neurotransmitters to signal across that gap. GLP-1 is one of them. Those nerve endings collect into the vagus nerve, the primary connection between the brain and the gut.

In a normal person, almost all the GLP-1 generated in the gut is used to signal to those vagus nerve endings. Only about 10 percent makes it into circulation beyond the liver, and that 10 percent is broken down within a minute. It's not supposed to be a hormone flooding the bloodstream.

The injections bypass the vagus nerve entirely

When you inject synthetic GLP-1 at high doses, it doesn't go through the gut. It doesn't signal to the vagus nerve. Instead, it floods the blood, crosses the blood-brain barrier, and activates GLP-1 receptors directly in the brain.

People assume that's the same as the normal route. Brown says it's not even close. There's not a one-to-one relationship between GLP-1 receptors in the gut and those in the brain. You're bypassing the system the body is designed to use.

And here's the problem: use it or lose it. If you don't use a muscle, it shrinks. The same applies to nerves. By bypassing the vagus nerve, the injections make it less active. Over time, it becomes more dysfunctional.

The vagus nerve controls more than hunger

The vagus nerve is part of the autonomic nervous system, the branch that manages everything involuntary: digestion, heart rate, blood pressure, bladder control, breathing. There are two branches to that system. Sympathetic is fight or flight. Parasympathetic is rest and digest.

In obesity, diabetes, heart disease and aging, there's a progressive shift toward too much sympathetic activity and not enough parasympathetic. That imbalance affects every organ system. Brown says dysfunction of the vagus nerve is a fundamental driver of obesity and diabetes in the first place.

The autonomic nervous system also regulates skeletal muscle. That's why people on GLP-1s are losing so much muscle. The injections are bypassing the vagus nerve, making it weaker, and that shows up in the muscles.

People with diabetes already have a broken vagus nerve

In people who are obese or have type 2 diabetes, fasting levels of GLP-1 in the blood are already higher than normal. When they eat, the GLP-1 response is weak. Brown says that's GLP-1 resistance, the same pattern you see with insulin in type 2 diabetes.

In type 2 diabetes, fasting insulin is high and the response to meals is blunted. Modern medicine often treats that by giving more insulin. It lowers blood glucose, which looks good, but all-cause mortality goes up dramatically once people start taking insulin shots. Brown says we're making the fundamental problem worse.

He thinks the same thing is happening with GLP-1 injections. In people with severe metabolic disease, the vagus nerve is already dysfunctional, almost end-stage. The injections won't do as much additional damage to those people, and it may make sense to use them.

But the studies on Ozempic, Wegovy and Mounjaro were done on people with diabetes and heart disease. The jump to using these drugs in people who just want to lose 20 or 30 pounds, people with healthier metabolisms, is huge. The assumption that the side effect profile will be the same is faulty.

Why this matters if you haven’t started yet: If you don't have diabetes or heart disease, your vagus nerve is healthier, which means these injections have more room to damage it.

The healthier you are, the worse the long-term damage

Brown says the people who are metabolically healthy respond best to GLP-1s because they don't have GLP-1 resistance. But in those people, the vagus nerve is still working. When you bypass it with injections, you're making it dysfunctional.

One measure of autonomic balance is heart rate variability, or HRV. It's a measure of how well the parasympathetic nervous system is functioning. In people who are metabolically healthy and use these injections, HRV goes down. That means decreased parasympathetic function and higher sympathetic activity.

Brown says a good argument could be made that in many people, these injections are accelerating the aging process.

What happens when you stop

Brown speculates that when people stop GLP-1 injections after using them with a healthy metabolism, there's a chance of cognitive decline. If the vagus nerve is now more dysfunctional than before, those people are going to be more insulin resistant. They'll struggle with high blood pressure. They'll be metabolically worse off than before they started.

That's the great paradox. The people who lose the most weight are the ones who will pay for it later.

You might say, hey, you're a bariatric surgeon, you're biased. Yeah, everybody has bias. I'm biased, I'm sure. But I've been thinking about this for a long time, many years.Idaho Bariatric & Metabolic Institute

Why bariatric surgery works differently

Brown says bariatric surgery produces much better long-term results than GLP-1 injections, and the reason is the opposite mechanism. Stapling the stomach and intestines restores vagus nerve activity. It's restoring normal physiology.

The injections bypass the system. They take a shortcut. In a lot of people, he says, it's going to be a net negative.

Brown says he doesn't hear anyone else talking about the vagus nerve, and he thinks someone has to. Patients are ordering these drugs online, bypassing doctors entirely. Doctors who do prescribe them need to understand what's happening long term.

The assumption that flooding the blood with synthetic GLP-1 is the same as the body's normal signaling system is wrong. The healthier you are when you start, the more you have to lose when you stop.

Questions people ask

Why do people lose muscle on Ozempic and Mounjaro?

Dr. Brown says GLP-1 injections bypass the vagus nerve, the connection between the brain and gut that also regulates skeletal muscle. When the nerve isn't used, it becomes weaker, and muscle loss follows. Studies show 38 to 50 percent of weight lost on GLP-1s is muscle.

Can Ozempic cause permanent stomach paralysis?

Some people who stop GLP-1 injections experience gastroparesis, a form of stomach paralysis with persistent nausea and vomiting. Dr. Brown says this happens because the drugs bypass and weaken the vagus nerve, which controls stomach movement.

Are GLP-1 drugs worse for healthy people than for diabetics?

Dr. Brown argues yes. People with diabetes already have vagus nerve dysfunction, so the drugs do less additional damage. Healthier people respond better to GLP-1s but may suffer worse long-term side effects because their vagus nerve has more room to degrade.

IB
Idaho Bariatric & Metabolic Institute

Dr. David Brown is a bariatric surgeon at the Idaho Bariatric & Metabolic Institute. He says 98% of his practice is weight loss, metabolism and bariatric surgery. 597,881 views on the original video.

Watch the original on YouTube →

Trending Topics